Related Experiment Videos
CA-125 monitored therapy with GnRH analogue of pelvic endometriosis
P Negri1, M A Ricciardelli, A Tomasi
1Clinica Ostetrica e Ginecologica, Università di Ferrara.
Acta Europaea Fertilitatis
|July 1, 1992
Abstract:
Thirteen patients affected by endometriosis have been treated with GnRH analogue Buserelin. CA-125 serum levels have been monitored before, during and after treatment. Analysis of data suggests the hypothesis of an individualized follow up by means of repeated assays of CA-125 and their reference to pre and post treatment graphs.